TrialBMC psychiatry2021

Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study.

Nagahide Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.